怀孕期间新发性风湿性关节炎:一个病例报告
Aiysha Gul1, Muzamil Khan2, Satkarjeet Kaur Gill3
1Obstetrics and Gynecology, Mardan Medical Complex, Mardan, PAK.
Cureus
|August 21, 2024
概括
本病例报告详细介绍了一例罕见的风湿性关节炎 (RA) 在怀孕期间发病的病例. 有效的治疗导致了症状缓解和健康的分娩,为预期母亲的RA管理提供了洞察力.
科学领域:
- 产科和妇科 产科和妇科
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
背景情况:
- 妊娠期间风湿性关节炎 (RA) 的发病非常罕见,原因是免疫系统适应支持胎儿发育.
- 怀孕诱导的免疫调节通常会抑制自身免疫性疾病,使新的RA诊断不太可能.
研究的目的:
- 报告怀孕期间出现的类风湿性关节炎病例.
- 讨论在孕妇患者中对RA的诊断挑战和管理策略.
- 为了突出RA治疗在妊娠和产后的结果.
主要方法:
- 一个26岁的孕妇在怀孕24周时出现了RA症状的病例报告.
- 临床评估,包括关节疼痛和胀的评估.
- 实验室调查:炎症标志物,类风湿因子 (RF) 和抗循环酸抗体.
- 用氧化 (HCQ),普雷迪尼索隆和类药物开始治疗.
主要成果:
- 活跃类风湿性关节炎的诊断通过临床表现和阳性血清学标记 (RF和抗CCP) 得到证实.
- 在接受HCQ,普雷迪尼索隆和白醇治疗后,RA症状显著改善.
- 没有与RA或其治疗相关的产后并发症.
- 顺利的阴道分娩一个健康的婴儿.
结论:
- 风湿性关节炎可以在怀孕期间表现出来,尽管典型的免疫耐受性.
- HCQ和普雷迪尼索隆的组合可以有效地控制孕妇患者的RA症状.
- 最佳的管理允许有利的母亲和胎儿的结果,包括成功的分娩.
相关概念视频
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...


